The goal of this clinical trial is to evaluate the safety and preliminary efficacy of a
1-year course of IVMED-85 eye drops for the treatment of pediatric myopia by assessing its
safety effects on visual acuity and its effect on the change and/or progression of myopia.
The main question[s] it aims to answer are:
- Does IVMED 85 improve visual acuity
- Does IVMED 85 slow or otherwise change the progression of myopia
Participants will use eyedrops twice a day for one year. Researchers will compare IVMED 85 to
a placebo.